I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
This gene can have permanent changes that cause it to function abnormally by making cancer cells grow. Gilteritinib may block the abnormal function of the FLT3 gene that makes cancer cells grow. The overall goals of this study are, 1) to compare the effects, good and/or bad, of CPX-351 with …
chemotherapy drug
methotrexate
gemtuzumab ozogamicin
blood count
mental retardation
- 0 views
- 2 annotations
- 19 Feb, 2024